Pages that link to "Q41932765"
Jump to navigation
Jump to search
The following pages link to Hydroxychloroquine treatment of patients with human immunodeficiency virus type 1. (Q41932765):
Displaying 50 items.
- Altered immune responses in rhesus macaques co-infected with SIV and Plasmodium cynomolgi: an animal model for coincident AIDS and relapsing malaria (Q27341794) (← links)
- Chloroquine could be used for the treatment of filoviral infections and other viral infections that emerge or emerged from viruses requiring an acidic pH for infectivity (Q28066142) (← links)
- Inflammatory arthritis in HIV positive patients: A practical guide (Q28072035) (← links)
- Rheumatoid arthritis in patients with HIV: management challenges (Q28075624) (← links)
- Chloroquine induces human mononuclear phagocytes to inhibit and kill Cryptococcus neoformans by a mechanism independent of iron deprivation (Q28379104) (← links)
- Effect of chloroquine on reducing HIV-1 replication in vitro and the DC-SIGN mediated transfer of virus to CD4 T-lymphocytes. (Q30359528) (← links)
- Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure? (Q30362489) (← links)
- Chloroquine for influenza prevention: a randomised, double-blind, placebo controlled trial (Q30402402) (← links)
- Impaired accessory cell function in a human dendritic cell line after human immunodeficiency virus infection (Q30448571) (← links)
- Sensitive and selective determination of hydroxychloroquine in the presence of uric acid using a new nanostructure self-assembled monolayer modified electrode: optimization by multivariate data analysis (Q30832816) (← links)
- The anti-HIV-1 activity of chloroquine (Q31884593) (← links)
- The potential place of chloroquine in the treatment of HIV-1-infected patients (Q31884618) (← links)
- Chloroquine modulates HIV-1-induced plasmacytoid dendritic cell alpha interferon: implication for T-cell activation (Q33613674) (← links)
- Development of clinical methods of iron deprivation for suppression of neoplastic and infectious diseases (Q33750450) (← links)
- Effects of chloroquine on viral infections: an old drug against today's diseases? (Q33973620) (← links)
- Chloroquine and the fungal phagosome (Q34022942) (← links)
- Reduction of immune activation with chloroquine therapy during chronic HIV infection (Q34296062) (← links)
- Development of polyether urethane intravaginal rings for the sustained delivery of hydroxychloroquine (Q34353780) (← links)
- HIV transmission through breastfeeding: problems and prevention (Q35153151) (← links)
- Impact of chloroquine on viral load in breast milk (Q35577255) (← links)
- Effect of chloroquine on human immunodeficiency virus (HIV) vertical transmission. (Q36276294) (← links)
- Impact of Hydroxychloroquine-Loaded Polyurethane Intravaginal Rings on Lactobacilli (Q36290546) (← links)
- Alternative modified infant-feeding practices to prevent postnatal transmission of human immunodeficiency virus type 1 through breast milk: past, present, and future (Q36391604) (← links)
- The molecular basis of chloroquine block of the inward rectifier Kir2.1 channel (Q36446243) (← links)
- Virus glycosylation: role in virulence and immune interactions (Q36775963) (← links)
- Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century (Q36880738) (← links)
- Inflammation, immune activation, and cardiovascular disease in HIV. (Q36957752) (← links)
- The Effect of Chloroquine on Immune Activation and Interferon Signatures Associated with HIV-1. (Q37062264) (← links)
- Rheumatic conditions in human immunodeficiency virus infection (Q37138780) (← links)
- Malaria and HIV co-infection in pregnancy in sub-Saharan Africa: impact of treatment using antimalarial and antiretroviral agents (Q37245300) (← links)
- Effects of hydroxychloroquine on immune activation and disease progression among HIV-infected patients not receiving antiretroviral therapy: a randomized controlled trial (Q37289596) (← links)
- Understanding and controlling chronic immune activation in the HIV-infected patients suppressed on combination antiretroviral therapy (Q38066127) (← links)
- The role and therapeutic potential of autophagy modulation in controlling virus-induced cell death. (Q38152376) (← links)
- Chloroquine and beyond: exploring anti-rheumatic drugs to reduce immune hyperactivation in HIV/AIDS. (Q38530430) (← links)
- Effects of malaria infection in human immunodeficiency virus type 1-infected Ugandan children (Q38887640) (← links)
- Immune Suppression by Myeloid Cells in HIV Infection: New Targets for Immunotherapy (Q39048479) (← links)
- Immunosenescence and hurdles in the clinical management of older HIV-patients (Q39170367) (← links)
- Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases (Q39360987) (← links)
- Development and in vitro evaluation of chloroquine gels as microbicides against HIV-1 infection (Q39964308) (← links)
- The ability of chloroquine to prevent tat-induced cytokine secretion by monocytes is implicated in its in vivo anti-human immunodeficiency virus type 1 activity. (Q40213471) (← links)
- Iron withholding: a defense against viral infections (Q41136325) (← links)
- Inhibition of HIV-1 replication by hydroxychloroquine: mechanism of action and comparison with zidovudine (Q41152773) (← links)
- Distribution of hydroxychloroquine in lymphoid tissue in a rabbit model for HIV infection (Q41907478) (← links)
- The additive in vitro anti-HIV-1 effect of chloroquine, when combined with zidovudine and hydroxyurea (Q41919627) (← links)
- Assessment of chloroquine as a modulator of immune activation to improve CD4 recovery in immune nonresponding HIV-infected patients receiving antiretroviral therapy (Q41921243) (← links)
- Comparison of hydroxychloroquine with zidovudine in asymptomatic patients infected with human immunodeficiency virus type 1 (Q41927429) (← links)
- Use of chloroquine in viral diseases (Q41932841) (← links)
- Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies (Q43280688) (← links)
- HIV as a Cause of Immune Activation and Immunosenescence (Q47151081) (← links)
- Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review. (Q54218397) (← links)